Literature DB >> 11072235

BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.

D Mertens1, S Wolf, L Bullinger, S Ohl, C Schaffner, H Döhner, S Stilgenbauer, P Lichter.   

Abstract

The most frequent chromosomal imbalance in B-cell chronic lymphocytic leukemia (B-CLL) and mantle-cell lymphoma (MCL) is loss of material from 13q14.3. BCMSUN (previously Leu2, t4, cDNA 1B4) is one of 3 proposed candidate genes isolated from the minimally deleted region. We identified a homolog of BCMSUN, termed BCMSUNL (for BCMSUN-like). Radiation-hybrid mapping with a PCR-amplified fragment and fluorescence in situ hybridization with 2 PAC clones containing coding information for BCMSUNL revealed its localization at 1p22-p31. Interphase fluorescence in situ hybridization, however, revealed that the BCMSUNL gene locus is not part of the critical deletion region of 1p22 in MCLs. Analysis of DNA sequences derived from the respective PAC clones and available in public databases uncovered an intronless structure of BCMSUNL. Compared to BCMSUN, the new gene lacks exon 2 and shows 90.3% homology on the nucleic acid level. Both genes are expressed in peripheral blood lymphocytes from healthy donors as well as B-CLL and MCL tumors, with retention of genetic material at 13q14.3. Therefore, analysis of the candidate tumor-suppressor gene BCMSUN at 13q14.3 must be based on assays that distinguish between the 2 homologous genes. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072235     DOI: 10.1002/1097-0215(20001201)88:5<692::aid-ijc2>3.0.co;2-3

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.

Authors:  Daniel Mertens; Stephan Wolf; Cordula Tschuch; Cora Mund; Dirk Kienle; Sibylle Ohl; Petra Schroeter; Frank Lyko; Hartmut Döhner; Stephan Stilgenbauer; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

2.  Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation.

Authors:  Fei Xu; Heshui Wu; Jiongxin Xiong; Tao Peng
Journal:  Front Mol Biosci       Date:  2021-04-22

3.  lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis.

Authors:  Yongchun Zhou; Hutao Shi; Yaqian Du; Guangqiang Zhao; Xiaoxiong Wang; Quan Li; Junxi Liu; Lianhua Ye; Zhenghai Shen; Yinjin Guo; Yunchao Huang
Journal:  Aging (Albany NY)       Date:  2019-09-20       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.